- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Mirabegron
Total 166 results
-
The Affiliated Ganzhou Hospital of Nanchang UniversityActive, not recruiting
-
Thomas Jefferson UniversityAstellas Pharma IncTerminatedAchalasiaUnited States
-
Astellas Pharma IncCompletedHealthy Subjects | Plasma Concentration of MirabegronJapan
-
Astellas Pharma IncCompletedHealthy Subjects | Bioavailability | Pharmacokinetics of MirabegronNetherlands
-
Cedars-Sinai Medical CenterRecruitingSyncope | Postural Orthostatic Tachycardia Syndrome | Chronic Orthostatic IntoleranceUnited States
-
Far Eastern Memorial HospitalRecruitingOveractive Bladder SyndromeTaiwan
-
Far Eastern Memorial HospitalRecruitingFemale Patients With Overactive Bladder SyndromeTaiwan
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Urinary Bladder Diseases | Urinary Bladder OveractiveUnited States, Armenia, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slov... and more
-
Peking Union Medical College HospitalNot yet recruiting
-
Astellas Pharma Europe B.V.Completed
-
Astellas Pharma China, Inc.CompletedPharmacokinetics of Mirabegron | Food Effect | Healthy Chinese SubjectsChina
-
CHU de Quebec-Universite LavalCompletedOveractive Bladder | Urinary Incontinence
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM178Japan
-
Samsung Medical CenterCompleted
-
Far Eastern Memorial HospitalWithdrawnOveractive Bladder SyndromeTaiwan
-
Seoul National University HospitalUnknown
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of MirabegronUnited States
-
Taipei Veterans General Hospital, TaiwanRecruitingOveractive Bladder SyndromeTaiwan
-
Buddhist Tzu Chi General HospitalUnknownOveractive Bladder SyndromeTaiwan
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Mild and Moderate Hepatic ImpairmentSlovakia
-
Astellas Pharma IncCompletedOveractive Bladder | PharmacokineticsFrance
-
Astellas Pharma China, Inc.CompletedUrge Incontinence | Overactive Bladder (OAB)China
-
Astellas Pharma IncCompletedRenal ImpairmentUnited States
-
Buddhist Tzu Chi General HospitalCompletedUrinary Incontinence | Overactive Bladder Syndrome
-
Astellas Pharma IncAstellas Pharma Taiwan, Inc.CompletedHealthy Volunteer | Pharmacokinetics of YM178Taiwan
-
University of Alabama at BirminghamCompletedOveractive BladderUnited States
-
Genuine Research Center, EgyptHikma PharmaCompleted
-
HealthPartners InstituteCompletedOveractive Bladder | Parkinson Disease | Impaired CognitionUnited States
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of MirabegronUnited States
-
National Taiwan University HospitalCompletedRecurrence of Overactive Bladder SyndromeTaiwan
-
Astellas Pharma IncCompleted
-
Chang Gung Memorial HospitalCompletedUrinary Bladder, Overactive | Sexual Behavior | Sexual Function Disturbances | Behavior Therapy | Sexual ActivityTaiwan
-
Astellas Pharma Global Development, Inc.RecruitingNeurogenic Detrusor OveractivityPhilippines, Turkey, Belgium, Denmark
-
Tianjin Medical University General HospitalRecruiting
-
Astellas Pharma IncCompleted
-
Philip KernNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
University Hospitals Cleveland Medical CenterWithdrawnOveractive BladderUnited States
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Neurogenic Detrusor OveractivityDenmark, Poland
-
Astellas Pharma Europe B.V.Completed
-
Unity Health TorontoCanadian Urological AssociationUnknown
-
Catalan Institute of HealthCompletedOveractive Bladder Syndrome
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of YM178Netherlands
-
Shachi TyagiNational Institute on Aging (NIA)RecruitingNocturia | Urgency Urinary IncontinenceUnited States
-
Ono Pharmaceutical Co. LtdCompleted
-
Aaron CypessNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...Completed
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of MirabegronFrance
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveChina, Taiwan, India, Korea, Republic of
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics | CardiovascularUnited Kingdom
-
Astellas Pharma IncCompletedPost-marketing Study to Evaluate the Effect of Mirabegron on the Plasma Concentration of TolterodineHealthy | Pharmacokinetics of Mirabegron and TolterodineJapan